Unlike the company's chosen names, "Cyberdyne" and "Hal" are not here to replace humanity.  Quite the opposite!  The exoskeleton devices made by CYBERDYNE are here to empower its customers!

CYBERDYNE was founded on 24 June 2004 as a University of Tsukuba venture to commercialize Professor Yoshiyuki Sankai’s Cybernics research. The company develops Cybernics systems for medical/welfare, care, workplace support, and related fields, and its current (2026) English product lineup includes Medical HAL, non-medical Well-Being HAL, HAL Lumbar systems, HAL peripherals, and other robotics/interface products.

CYBERDYNE is one of the oldest and most respected exoskeleton companies in the world.  It has been a trailblazer in the technology field and has helped put exoskeleton technology on the map (see map of exoskeleton producers).

You can recognize wearable robots from CYBERDYNE by their reliance on bio-signal control, which is collected by sensors temporarily attached to the user's skin. More formally: HAL systems use non-invasive sensors to detect faint bioelectrical signals on the skin's surface and assist movement in response to the wearer’s intended motion.

Medical HAL Lower Limb has EU CE marking listed by CYBERDYNE, and the FDA database lists the Medical HAL Lower Limb Type under powered exoskeleton 510(k) K233695 with a substantially equivalent decision date of May 7, 2024. CYBERDYNE also states that the small-sized Medical HAL model is now approved or cleared in the U.S., Europe, and Japan. (see Intended Use of the 11 FDA-Approved Medical Exoskeletons in 2023 for a landscape overview)

CYBERDYNE is a publically traded company: OTCMKTS: CYBQY. It is publicly listed on the Tokyo Stock Exchange Growth Market under stock code 7779, sponsored Level I ADR, traded OTC under ticker CYBQY.